A trial has been conducted on the use of vagus nerve stimulation for rheumatoid arthritis, with results and future directions being reported. The treatment has shown efficacy in rheumatoid arthritis and a vagus nerve stimulation device has been approved by the FDA. The approval of this device may represent a significant development in the treatment of rheumatoid arthritis, with some outlets suggesting it could be a pivotal moment for the field.